Irene Escudero-Martínez

Irene Escudero-Martínez

Auto-generated profile, based on publicly available information

Irene Escudero-Martínez

Unidad de Ictus, Unidad de Gestión Clínica de Neurociencias, Hospital Universitario Virgen del Rocío, Sevilla, España

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2023 in Trends in Cardiovascular Medicine
Verified
Journal Article
Closed access
IEIrene Escudero-Martínez
Irene Escudero-Martínez
LMLluis Morales-Caba
Lluis Morales-Caba
Tomás SeguraTomás Segura
Tomás Segura

1 December 2019 in European Stroke Journal
Verified
Journal Article
Open access
PDF file
NANiaz Ahmed
Niaz Ahmed
HAHeinrich Audebert
Heinrich Audebert
GTGuillaume Turc
Guillaume Turc
CCCharlotte Cordonnier
Charlotte Cordonnier
HCHanne Christensen
Hanne Christensen
TSThorsten Steiner
Thorsten Steiner
The purpose of the European Stroke Organisation–Karolinska Stroke Update Conference is to provide updates on recent stroke therapy research and to give an opportunity for the participants to discuss how these results may be implemented into clinical routine. The meeting started 22 years ago as Karolinska Stroke Update, but since 2014 it is a joint conference with European Stroke Organisation. Importantly, it provides a platform for discussion on the European Stroke Organisation guidelines process and on recommendations to the European Stroke Organisation guidelines committee on specific topics. By this, it adds a direct influence from stroke professionals otherwise not involved in committees and work groups on the guideline procedure. The discussions at the conference may also inspire new guidelines when motivated. The topics raised at the meeting are selected by the scientific programme committee mainly based on recent important scientific publications. This year’s European Stroke Organisation–Karolinska Stroke Update Meeting was held in Stockholm on 11–13 November 2018. There were 11 scientific sessions discussed in the meeting including two short sessions. Each session except the short sessions produced a consensus statement (Full version with background, issues, conclusions and references are published as web-material and at www.eso-karolinska.org and http://eso-stroke.org) and recommendations which were prepared by a writing committee consisting of session chair(s), scientific secretary and speakers. These statements were presented to the 250 participants of the meeting. In the open meeting, general participants commented on the consensus statement and recommendations and the final document were adjusted based on the discussion from the general participants Recommendations (grade of evidence) were graded according to the 1998 Karolinska Stroke Update meeting with regard to the strength of evidence. Grade A Evidence: Strong support from randomised controlled trials and statistical reviews (at least one randomised controlled trial plus one statistical review). Grade B Evidence: Support from randomised controlled trials and statistical reviews (one randomised controlled trial or one statistical review). Grade C Evidence: No reasonable support from randomised controlled trials, recommendations based on small randomised and/or non-randomised controlled trials evidence.

1 January 2020 in Stroke
Verified
Journal Article
Closed access
MTMagnus Thorén
Magnus Thorén
ADAnand Dixit
Anand Dixit
IEIrene Escudero-Martínez
Irene Escudero-Martínez
ZGZuzana Gdovinová
Zuzana Gdovinová
LKLukáš Klečka
Lukáš Klečka
NANiaz Ahmed
Niaz Ahmed
Background and Purpose—: A large infarct and expanding cerebral edema (CED) due to a middle cerebral artery occlusion confers a 70% mortality unless treated surgically. Reperfusion may cause blood-brain barrier disruption and a risk for cerebral edema and secondary parenchymal hemorrhage (PH). We aimed to investigate the effect of recanalization on development of early CED and PH after recanalization therapy. Methods—: From the SITS-International Stroke Treatment Registry, we selected patients with signs of artery occlusion at baseline (either Hyperdense Artery Sign or computed tomography/magnetic resonance imaging angiographic occlusion). We defined recanalization as the disappearance of radiological signs of occlusion at 22 to 36 hours. Primary outcome was moderate to severe CED and secondary outcome was PH on 22- to 36-hour imaging scans. We used logistic regression with adjustment for baseline variables and PH. Results—: Twenty two thousand one hundred eighty-four patients fulfilled the inclusion criteria (n=18 318 received intravenous thrombolysis, n=3071 received intravenous thrombolysis+thrombectomy, n=795 received thrombectomy). Recanalization occurred in 64.1%. Median age was 71 versus 71 years and National Institutes of Health Stroke Scale score 15 versus 16 in the recanalized versus nonrecanalized patients respectively. Recanalized patients had a lower risk for CED (13.0% versus 23.6%), adjusted odds ratio (aOR), 0.52 (95% CI, 0.46–0.59), and a higher risk for PH (8.9% versus 6.5%), adjusted odds ratio, 1.37 (95% CI, 1.22–1.55), than nonrecanalized patients. Conclusions—: In patients with acute ischemic stroke, recanalization was associated with a lower risk for early CED even after adjustment for higher rate for PH in recanalized patients.

1 January 2018 in International Journal of Cardiology
Verified
Journal Article
Closed access
JPJorge Pagola
Jorge Pagola
JJJesus Juega
Jesus Juega
JFJaume Francisco-Pascual
Jaume Francisco-Pascual
AMAngel Moya
Angel Moya
MSMireia Sanchis
Mireia Sanchis
AEArturo Evangelista
Arturo Evangelista

1 March 2018 in Journal of Stroke and Cerebrovascular Diseases
Verified
Journal Article
Closed access
EZElena Zapata-Arriaza
Elena Zapata-Arriaza
FMFrancisco Moniche
Francisco Moniche
PBPardo-Galiana Blanca
Pardo-Galiana Blanca
ABAlejandro Bustamante
Alejandro Bustamante
IEIrene Escudero-Martínez
Irene Escudero-Martínez
JMJoan Montaner
Joan Montaner

1 August 2016 in Stroke
Verified
Journal Article
Closed access
PDF file
EZElena Zapata-Arriaza
Elena Zapata-Arriaza
FMFrancisco Moniche
Francisco Moniche
AGAlejandro González
Alejandro González
ABAlejandro Bustamante
Alejandro Bustamante
IEIrene Escudero-Martínez
Irene Escudero-Martínez
JMJoan Montaner
Joan Montaner
Background and Purpose—: Restenosis after carotid angioplasty (with or without stent) is associated with increased rate of stroke and death. Our aim was to determine risk and predictive factors related to carotid restenosis post carotid angioplasty and its association to recurrent cerebrovascular events. Methods—: All consecutive patients with carotid stenosis treated with angioplasty (n=1060) in a single University Hospital were included (from 2002 to 2013). Follow-up was done prospectively evaluating restenosis, ipsilateral stroke, or death. Restenosis was defined as a narrowing of ≥70% of a previously treated vessel evaluated by ultrasonography. Results—: Of the 1060 patients treated, 9.2% (97) of patients experienced restenosis during follow up (median 12 [9–32] months). Occurrence of restenosis was associated with ipsilateral stroke during follow-up ( P =0.049). After Cox regression analysis, hypertension (hazard ratio, 6.2 [1.9–19.9]; P =0.002), impaired vasoreactivity (hazard ratio, 1.7 [1.09–2.8]; P =0.019), and angioplasty without stent (hazard ratio, 2.9 [1.2–6.8]; P =0.012) were independent risk predictors of >70% restenosis. Conclusions—: Carotid restenosis after carotid angioplasty is associated with ipsilateral stroke occurrence. In our sample, hypertension, angioplasty without stent, and impaired vasoreactivity identify patients at high risk of restenosis and could help to select patients for follow-up ultrasonography imaging.